SHS stands for life science and medical technology investments.
For more than 25 years.
Our investment focus
From growth to medium-sized companies: We invest in fast-growing companies in the life science and medical technology sector.
From cardiology to digital health: Our portfolio currently comprises more than 20 companies from the various life science and medical technology sub sectors.
From pension funds to family offices: For many years partners have entrusted us with their capital in order to achieve attractive returns on it.
Experience for morethan 25 years
Since its foundation in 1993, SHS has been investing in innovative companies in the life science and medical technology sectors.
With our investments, we help shape European champions in their respective healthcare segments or support them in their further expansion.
In addition to capital, we essentially provide our networks and expertise in the areas of approval and reimbursement in the USA and China, marketing/sales, staffing and exit.
Years of history
Million €current fund volume
Million € AUM(ca.)
Transactions assessments p.a.(ca.)
11 October 2021 - Press Releases
22 September 2021 - SHS News
13 September 2021 - Press Releases